Friday, Feb 14 2025 | Time 17:59 Hrs(IST)
image
Business EconomyPosted at: Jan 13 2025 6:13PM


Aragen secures USD 100 Mn investment from Quadria Capital

New Delhi, Jan 13 (UNI) Research and Development organization Aragen on Monday announced that it has secured a USD 100 Million investment from Quadria Capital, an Asia healthcare-focused Private Equity fund.
The investment will result in Quadria acquiring a minority stake in Aragen, at an approximate valuation of USD 1.4 Billion, primarily through a fresh capital infusion, with a small portion from the sale of shares by existing investors, the company said in a release.
This funding will support Aragen’s strategic expansion of its capabilities and infrastructure, enabling the company to meet the growing demand for outsourcing services from innovators in the US and Europe.
Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences industries. It offers a range of solutions across the drug discovery, development and manufacturing continuum to advance small and large-molecule programs.
With this investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen. This partnership further solidifies Aragen's reputation for delivering high-quality “concept to clinic” and “concept to commercial” services to its global customer base comprising all sectors of health – Human, Animal and Plant. The announcement comes ahead of JPM Week 2025, where Aragen is expected to secure additional outsourcing partnerships.
“We are delighted to welcome Quadria to Aragen. This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market,” said Manni Kantipudi, CEO, Aragen Life Science. “Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing services, and, most importantly, help our customers accelerate their programs to market faster and more efficiently.”
Coupled with its 23-year history of servicing global customers across all health sectors, Aragen is well-positioned to benefit from macro trends in the outsourcing market, with Western innovator companies increasingly seeking to diversify and secure their supply chain as a hedge against operational disruptions due to global factors.
The company’s ability to deliver world class scientific solutions — from early discovery through to commercial manufacturing for small molecules and biologics — has seen it grow its global clientele
to 400+ clients, including 15 of the top 20 large pharma.
Dr. Amit Varma, Managing Partner and co-Founder of Quadria Capital, said, "The pharmaceutical outsourcing sector presents compelling growth opportunities, especially in the current environment which is driven by global supply chain reorganization. Aragen's impressive track record, customer-centric approach, and commitment to innovation make it an ideal partner for global pharmaceutical companies. We look forward to partnering with them and supporting their next phase of growth."
This investment marks another milestone in Quadria’s continued focus on high-growth opportunities in the healthcare sector. Quadria has a strong track-record of successful investments in leading outsourced pharmaceutical services companies, including Akums Drugs (India’s largest domestic focused contract manufacturer), Encube Ethicals (India-based topicals focused CDMO) and Straits Orthopedics (Malaysia-based CDMO for orthopedic medical devices).
UNI SKB BM
Please log in to get detailed story.
Tags: #Aragen secures USD 100 Mn investment from Quadria Capital
More News

Reliance Consumer acquires Velvette, strengthens FMCG portfolio

14 Feb 2025 | 5:14 PM

Chennai, Feb 14 (UNI) Reliance Consumer Products Limited (RCPL) on Friday announced the acquisition of Velvette, the iconic FMCG brand renowned for revolutionizing personal care with
its innovative sachet packaging.

see more..
Hyundai completes 25 yrs of exports from India

Hyundai completes 25 yrs of exports from India

14 Feb 2025 | 5:08 PM

Chennai, Feb 14 (UNI) Passenger car markers Hyundai Motor India Limited (HMIL) on Friday said it has completed 25 years of exports from India, reinforcing its position as the country's largest exporter of passenger vehicles.

see more..

Titagarh Rail Systems secures order from Adani Cement for 16 rakes of wagons

14 Feb 2025 | 5:07 PM

Kolkata, Feb 14 (UNI) Titagarh Rail Systems Limited (TRSL), a leading Indian rolling stock manufacturer, has been awarded a significant contract from Ambuja Cements Limited and ACC Limited, part of Adani Cement.

see more..
Sensex down 199 76 pts

Sensex down 199 76 pts

14 Feb 2025 | 4:21 PM

Mumbai, Feb 14 (UNI) The equity market remained in the red for the eighth consecutive session on Friday, as BSE Sensex dropped 199.76 pts to settle at 75,939.21 amid a mixed trend in the Asian Market.

see more..

Texmaco Rail & Engineering and Trinity Rail Group sign global supply svc agreement

14 Feb 2025 | 2:40 PM

Kolkata, Feb 14 (UNI Texmaco Rail & Engineering Limited, a preeminent provider of rail solutions in India, and Trinity Rail Group LLC, a global leader in advanced rolling stock leasing and manufacturing solutions for the North American market, have entered into a Global Supply & Services Agreement, official sources said on Friday
This strategic alliance will target multiple areas of collaboration, including the design, development, and innovation of rolling stock and its components for Indian and international markets. Under this agreement, Texmaco will become a pivotal source for rolling stock components including foundry products in North America and other potential global regions.

see more..
image